The final version of EU GMP Annex 1 is an opportunity for industry to apply solutions that emphasize advanced technologies and allow Pharma companies to speed up their processes, reduce human error to ensure that final products are protected from microbial, particulate and pyrogen contamination and are safe for patients. This webinar will discuss the requirements that may impact your organization.
Complete the form below to access the on-demand webinar:
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
1.877.787.0177
510.732.0177
22320 Foothill Blvd. Suite 330, Hayward CA 94541